Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-16 11:45 am Sale | 2023-12-31 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 3,000,000 3.700% | -2,000,000 (-40.00%) | Filing History |
| 2023-02-14 10:40 am Purchase | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 5,000,000 8.100% | 2,535,000 (+102.84%) | Filing History |
| 2022-01-24 08:22 am Purchase | 2022-01-13 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 2,465,000 5.100% | 2,465,000 (New Position) | Filing History |
| 2021-01-05 3:12 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | SINGER JAMES R | 3,000,000 4.700% | 150,000 (+5.26%) | Filing History |
| 2020-03-27 08:56 am Purchase | 2020-03-17 | 13G | Ovid Therapeutics Inc. OVID | SINGER JAMES R | 2,850,000 5.200% | 495,000 (+21.02%) | Filing History |